Skip to content

CURASAN: sector benchmark

Where does a company stand against its sector? Every ratio over five fiscal years, with its place among its peers and what that means, ready to print for your client.

Sector benchmark

CURASAN

BE 0752.980.415
NACE 47.730, Retail sale of pharmaceutical products
NACE division 47, Retail trade all sizesfiscal years 2021 to 202527,017 to 32,568 sector peers per ratio

Summary

fiscal year 2025

CURASAN does better than half of its sector on 7 of the 7 ratios compared.

most favourable quarter above the median below the median least favourable quarter
Strongest points
  • Interest coveragebetter than 95%
  • Working-capital ratiobetter than 95%
  • Return on assetsbetter than 93%
Points to watch

No ratio below the sector median.

    Solvency and debt

    How soundly the company is financed.
    Solvency
    87.5%▼2025

    Solvency is above 93% of 32,488 sector peers: in the most favourable quarter.

    Position against the sector stable since 2021.

    20212022202320242025
    Debt to equity
    0.14▲2025

    Debt to equity is below 77% of 32,106 sector peers: in the most favourable quarter.

    Position against the sector stable since 2021.

    20212022202320242025
    Interest coverage
    713.90▲2025

    Interest coverage is above 95% of 29,199 sector peers: in the most favourable quarter.

    Position against the sector stable since 2021.

    20212022202320242025

    Liquidity

    Whether it can pay its short-term bills.
    Current ratio
    7.69▲2025

    The current ratio is above 92% of 32,316 sector peers: in the most favourable quarter.

    Position against the sector stable since 2021.

    20212022202320242025
    Working-capital ratio
    83.2%▲2025

    The working-capital ratio is above 95% of 32,412 sector peers: in the most favourable quarter.

    Position against the sector improving since 2021.

    20212022202320242025

    Profitability

    What the company earns on its assets and its sales.
    Return on equity
    33.3%▲2025

    Return on equity is above 77% of 27,017 sector peers: in the most favourable quarter.

    Position against the sector improving since 2021.

    20212022202320242025
    Return on assets
    29.1%▲2025

    Return on assets is above 93% of 32,568 sector peers: in the most favourable quarter.

    Position against the sector improving since 2021.

    20212022202320242025

    Not computable

    Long-term debt ratio, Net margin, EBITDA margin, Gross margin, Days sales outstanding, Days payable outstanding, Days inventory. This company files the abbreviated or micro schema, in which turnover and purchases are optional; margins and credit terms therefore cannot be taken from its figures.

    Source: filed annual accounts (NBB) and main activity (CBE register). Compared per fiscal year with each peer's latest statutory accounts; at least 30 peers per ratio. Prepared on 29 September 2026 via checked.be.